Related Experiment Video
Updated: Jun 2, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with
Elizabeth S McDonald1, Tien-Chi Pan2,3, Dhruv K Pant2,3
1Division of Breast Imaging, Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
The progesterone receptor membrane component 1 (PGRMC1)–sigma-2 receptor (σ2R/TMEM97)–low-density lipoprotein receptor (LDLR) complex components are linked to breast cancer recurrence. TMEM97 and PGRMC1 indicate higher risk, particularly in ER+ disease, guiding future therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- A ternary complex involving PGRMC1, σ2R/TMEM97, and LDLR plays a role in cholesterol transport.
- The prognostic significance of individual components of this complex in breast cancer remains to be fully elucidated.
Purpose of the Study:
- To investigate PGRMC1, σ2R/TMEM97, and LDLR as prognostic breast cancer biomarkers.
- To define their expression patterns in established molecular subtypes of breast cancer.
- To assess their association with cellular proliferation and recurrence-free survival.
Main Methods:
- Analysis of 4,463 invasive breast cancers using gene expression signature-based assays for proliferation.
- Cox proportional hazards regression and multivariate Cox analysis for relapse-free survival.
- Stratification of PGRMC1–σ2R/TMEM97–LDLR expression by immunohistochemistry, molecular subtype, tumor grade, and size.
Main Results:
- TMEM97 showed the strongest correlation with cellular proliferation, especially in estrogen receptor (ER)-positive disease (r = 0.59).
- TMEM97 and PGRMC1 expression were associated with an increased risk of early recurrence, particularly in ER+/HER2− disease (HR = 1.5) and ER+ malignancies (HR = 1.49).
- No increased recurrence risk was observed in ER−/HER2− or ER− disease based on TMEM97 expression.
Conclusions:
- Components of the PGRMC1–σ2R/TMEM97–LDLR complex are biomarkers associated with cellular proliferation and early breast cancer recurrence.
- These findings can guide further research into their role in aggressive disease and potential therapeutic targets.
- Understanding the interplay of proliferation and cholesterol metabolism in breast cancer is crucial for malignant transformation and propagation.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

